Ash Jayagopal: Closing the Clinical Research Innovation Gap | Breaking Protocol Season 2 - Ep 5
Clinical trials have become more scientifically sophisticated, yet many of the operational challenges behind them remain stubbornly unchanged. In this episode of Breaking Protocol, Ram Yalamanchili speaks with Ash Jayagopal, Chief Scientific and Development Officer at Opus Genetics, about the realities of running clinical trials in the era of gene therapy and ultra-rare diseases. Ash brings a rare perspective from the front lines of ophthalmology drug development, where some programs target patient populations measured in the hundreds rather than the thousands. In these environments, traditio…